2022
Exports | Imports
$4.72B | $2.78BWorld Rnk 13 / 208
Flag Rnk 6 / 1212
World Rnk 20 / 225
Flag Rnk 7 / 1213
2022
ECONOMIC COMPLEXITY of Sweden
1.5Rnk 7 / 124
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.47Rnk 46 / 1025

About

Exports In 2022, Sweden exported $4.72B in Vaccines, blood, antisera, toxins and cultures, making it the 13th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in Sweden. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Sweden are: United States ($1.18B), Germany ($793M), China ($484M), Austria ($306M), and France ($233M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Sweden between 2021 and 2022 were United States ($629M), China ($410M), and Austria ($230M).

Imports In 2022, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, becoming the 20th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in Sweden. Sweden imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($740M), Germany ($685M), Belgium ($439M), Netherlands ($198M), and Switzerland ($162M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Sweden between 2021 and 2022 were Belgium ($239M), United States ($96.6M), and South Korea ($40M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Sweden to the United States.

Latest Trends

December 2023

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (December 2022 - December 2023)SEK106M(2.32%)
IMPORT GROWTH (December 2022 - December 2023)SEK51.8M(2.9%)
MAIN EXPORTER (December 2023)
MAIN DESTINATION (December 2023)United StatesSEK1.06B

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Sweden. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$4.72B
IMPORTS (2022)$2.78B
NET TRADE (2022)$1.95B

In 2022, Sweden exported $4.72B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Sweden exports on Vaccines, blood, antisera, toxins and cultures were United States ($1.18B), Germany ($793M), China ($484M), Austria ($306M), and France ($233M).

In 2022, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($740M), Germany ($685M), Belgium ($439M), Netherlands ($198M), and Switzerland ($162M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Sweden WERE (2021 - 2022):
United States$629M (115%)
China$410M (559%)
Austria$230M (304%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Sweden WERE (2021 - 2022):
Norway-$120M (-90.3%)
Denmark-$33.6M (-33.9%)
Switzerland-$25.9M (-40.4%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Sweden's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Sweden's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with